7
Participants
Start Date
June 30, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
alfimeprase
Alfimeprase will be given as a single bolus of 1mg/2mL, or a split bolus of 5mg/2mL or 10mg/2mL in a three-tier dose escalation format. The 5mg and 10mg doses will be administered as split doses with 1/2 of the total dose given initially and 1/2 of the total dose given 30 minutes after the initial dose.
Columbia Presbyterian Medical Center, New York
Albany Medical Center Hospital, Albany
Kalieda Health, MFH, Buffalo
University of Pittsburg Medical Center, Pittsburgh
Norton Hospital, Louisville
Riverside Methodist Hospital, Columbus
University of Cincinnati, Cincinnati
Michigan State University, Sparrow Hospital, Lansing
Ruan Neurology & Clinical Research Center, Des Moines
University of Iowa Hospital, Iowa City
St. Luke's Medical Center, Milwaukee
University of Iowa Hospital, Iowa City
Northwestern Medical Center, Chicago
University of Kansas School of Medicine, Via Christi Regional Medical Center, Wichita
Baylor College of Medicine, Houston
UCLA Medical Center, Los Angeles
Oregon Stroke Center, Portland
University of Calgary, Foothills Medical Centre, Calgary
Vancouver General Hospital, Vancouver
Trilium Health Center, Mississauga
University Health Network Toronto, Toronto
Montreal Neurological Institute, Montreal
Lead Sponsor
ARCA Biopharma, Inc.
INDUSTRY